CFIM
Client First Investment Management’s Eli Lilly LLY Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.92M | Buy |
2,466
+5
| +0.2% | +$3.9K | 1.18% | 12 |
|
|
2025
Q1 | $2.03M | Buy |
2,461
+4
| +0.2% | +$3.3K | 1.38% | 7 |
|
|
2024
Q4 | $1.9M | Buy |
2,457
+4
| +0.2% | +$3.09K | 1.22% | 10 |
|
|
2024
Q3 | $2.17M | Buy |
2,453
+4
| +0.2% | +$3.54K | 1.66% | 8 |
|
|
2024
Q2 | $2.22M | Buy |
2,449
+3
| +0.1% | +$2.72K | 1.72% | 8 |
|
|
2024
Q1 | $1.9M | Buy |
2,446
+5
| +0.2% | +$3.89K | 1.51% | 9 |
|
|
2023
Q4 | $1.42M | Buy |
+2,441
| New | +$1.42M | 1.38% | 14 |
|